Erwiderung

Literatur

• 1 Kliche K O, Schalhorn A, Höffken K. Nachweis von DPD-Exon-14-Skipping vor 5-Fluoruracil-Behandlung?.  Dtsch Med Wochenschr. 2002;  127 463-464
• 4 Johnson M R, Wang K, Diasio R B. Profound dihydropyrimidine dehydrogenase deficiency resulting from a novel compound heterozygote genotype.  Clin Cancer Res. 2002;  8 768-774
• 3 Behnke D. et al . Prevalence of a Common Point Mutation in the Dihydropyrimidine Dehydrogenase (DPD) Gene within the 5’-Splice Donor Site of Intron 14 Patients with Severe 5-Fluorouracil (5-FU)-related Toxicity Compared with Controls (Reply).  Clin Cancer Res. 2001;  7 2832-2839

Autor